Production & creation integration Dream Qin Chuangyuan → "Shaanxi Miaokang Medical Tech Co., LTD." amazing debut!

In 2019, Yang Huanglong, who is already well-known in the field of medical device sales,turned his attention to the upstream industry and decided to engage in the research and development and production of pneumatic ballistic-type external pressure wave therapy instrument. Yang Huanglong is an activist, since the determination, immediately put into action, during that time, for the company's location, he ran a lot of places.

This incident made Yang Huanglong personally feel the good business environment and pragmatic work style of Fengxi New City. Later, Yang Huanglong went to the western Yungu consulting office space, R & D plant, the staff received him very warmly, and gave the company strong support in terms of policy. Through repeated contacts, Yang Huanglong deeply felt the entrepreneurial and innovative atmosphere of Fengxi New City, and finally chose to set up a company here. With the support of a good business environment and policy environment, Miaokang Medical started as a sprint, and in April 2019, the company was established. In May 2020, the research and development of two generations of products and prototype production were completed. In March 2021, the products submitted for inspection passed the national standard and the line standard performance test. In May 2022, the medical device production license was obtained, and the product was officially listed. At present, the pneumatic ballistic-type external pressure wave therapy instrument has been put into clinical use in medical institutions in Gansu, Sichuan, Liaoning and other places.

In 2022, Miaokang Medical was recognized as a "National high-tech enterprise" and "National science and technology small and medium-sized enterprise", and won the second prize of the "Three new Three small" excellent achievements of Shaanxi Province enterprises in 2022, the finalist of the "Force List" of Qin Chuangyuan in 2022, and the "Xi 'an Talent Plan" young talent project. The integration of production and innovation, the pursuit of dreams, and the innovation story of Miaokang Medical is the epitome of the transformation of Fengxi New City from enterprise achievements to the construction of a full range of scientific and technological service support, and the in-depth practice of the integration of "two chains". In 2021, a total of 81 enterprises in Fengxi New City were approved as state-level high-tech enterprises, an increase of 92.9%. In 2022, a total of 163 enterprises were approved as State-level high-tech enterprises, an increase of 101.2%. Up to now, there are 382 state-level high-tech enterprises and 869 technology-based smes in Fengxi New City. In the future, more national high-tech enterprises will emerge in Fengxi New City, which will accumulate capacity for the construction of Qinchuangyuan general window and high-quality development.